Hemorrhagic Myocardial Infarction Detection by Biomarkers

Last updated: April 4, 2025
Sponsor: Indiana University
Overall Status: Completed

Phase

N/A

Condition

Heart Defect

Coronary Artery Disease

Hypercholesterolemia

Treatment

N/A

Clinical Study ID

NCT05872308
13081
  • Ages > 18
  • All Genders

Study Summary

Pilot trial to determine diagnostic efficacy of post-reperfusion troponin kinetics in detection of hemorrhagic myocardial infarction

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥ 18 years

  2. Index STEMI

  3. Coronary angiogram with PCI to occur irrespective of the onset of the symptoms.

  4. Ability to provide informed consent for themselves

Exclusion

Exclusion Criteria:

  1. History of prior myocardial infarction,

  2. Cardiogenic shock,

  3. Patients who present with current cardiac arrest

  4. Any contraindication to cardiac CMR (claustrophobia, pacemaker or cardiacdefibrillator, known allergy to gadolinium),

  5. Presence of permanent atrial fibrillation,

  6. Unconscious patient,

  7. Severe renal insufficiency (creatinine clearance ≤ 30 ml/min/m2 or renal replacementtherapy),

  8. Women who are pregnant or breastfeeding. Women of reproductive potential must have anegative pregnancy test.

Study Design

Total Participants: 227
Study Start date:
July 08, 2022
Estimated Completion Date:
January 21, 2025

Connect with a study center

  • Synergy Superspecialty Hospital

    Rājkot,
    India

    Site Not Available

  • IU Methodist Hospital

    Indianapolis, Indiana 46202
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.